Treatment-related amyloid clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapies. [PDF]
La Joie R +14 more
europepmc +1 more source
Comparative evaluation of 5 combination adjuvants on immunogenicity and efficacy of approved seasonal influenza vaccines. [PDF]
Hernandez-Davies J +18 more
europepmc +1 more source
Review of TRAC : Outcomes of consultation and report to the HEFCE Board from the TRAC Review Group [PDF]
core
Imaging CRISPR-edited CAR-T cell therapies with optical and positron emission tomography reporters. [PDF]
Sanchez-Pupo RE +10 more
europepmc +1 more source
Therapeutic applications of CRISPR-Cas9 gene editing. [PDF]
Bharti A, Mudge J.
europepmc +1 more source
Prospects for Development and Commercialisation of Allogeneic CAR-Based Therapies for Autoimmune Disease. [PDF]
Osborne M, Maher J.
europepmc +1 more source
Double-strand break-free epigenetic programming: a safer path for T-cell therapies. [PDF]
Deng L, Yang Y, El-Osta A.
europepmc +1 more source
Improving CAR T cell therapy against malignancies through gene knock-down/out strategies: a systematic review. [PDF]
Karimi A +11 more
europepmc +1 more source

